The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Leading Laurel Rider McCarthy Breaks Wrist
- Favored Act of War Captures Cape Guineas
- CHRB Eyes Scratching of Unreported Geldings
- California Chrome Drills at Los Alamitos
- Bayern Turns in Bullet Move at Santa Anita
- Old Friends to Receive Special Eclipse Award
- Travis Stone Named Churchill Downs Announcer
- Rodenticide Linked to Six Sudden Horse Deaths
- Emerald Downs Purses to Rise 20% in 2015
- Bridlewood Owner Malone Purchases Ballylinch